NEW YORK, April 27, 2026, 12:03 EDT
- Rocket Lab shares slipped Monday, with investors navigating near-term technical headwinds while still eyeing the company’s broader space-infrastructure ambitions.
- Next up: Rocket Lab will post its first-quarter numbers after the U.S. market shuts on May 7.
- SpaceX’s upcoming IPO has stirred up interest in publicly traded space stocks—though it’s also putting more pressure on rivals to deliver, both operationally and when it comes to valuation.
Rocket Lab shares slipped on Monday, with the stock giving up about 2.3% to trade at $77.83. A new technical call pointed to waning short-term sentiment, though investor appetite for space names overall remained strong. Prices bounced between $77.11 and $81.11 through the session, keeping up the recent choppiness for one of Wall Street’s high-profile space plays.
It’s a pivotal moment for the stock, tugged both ways. Investors are scrambling to gauge Rocket Lab’s next chapter ahead of its May 7 earnings, even as SpaceX’s anticipated public debut is shaking up the way space stocks get priced.
On Sunday, Stock Traders Daily’s Quantitative Research Desk flagged weak short-term sentiment, hinting it could set up a shift in the mid- or long-term view. The team also noted resistance facing a test—a price spot that tends to attract selling. If resistance sticks, traders typically scan for support further down.
Pressure ramped up after last week’s abrupt slide. A Yahoo Finance piece, citing Zacks, noted Rocket Lab finished at $86.64—off 3.15% for the day, underperforming the wider market. That move had traders eyeing the stock, rethinking whether the recent rally was losing steam.
Rocket Lab’s numbers landed with impact. The company logged 2025 revenue of $602 million, a 38% increase, alongside a backlog that climbed to $1.85 billion. For the first quarter, executives are projecting revenue between $185 million and $200 million—an implied 57% year-on-year bump at the midpoint.
On the operations side, wins keep stacking up. Rocket Lab pulled off its second straight dedicated launch for Japan’s JAXA on April 23, sending eight spacecraft into orbit from New Zealand—its 87th launch to date. Chief Executive Sir Peter Beck pointed to the consecutive JAXA missions as evidence that Electron has become “the preferred small launcher for national space agencies.” Rocket Lab Corporation
The company rolled out a high-performance star tracker—think spacecraft navigation by starlight. Brad Clevenger, president of Rocket Lab USA, called it a response to “changing needs of commercial and government missions.” It’s a targeted move, part of Rocket Lab’s broader push to expand sales beyond launches and deepen its space systems business. Rocket Lab Corporation
SpaceX is at the center of the market’s attention. Reuters broke the story earlier this month: Elon Musk’s company has quietly submitted paperwork for a U.S. IPO, opening the door to public investors with a possible price tag exceeding $1.75 trillion. “Investors were clamoring for SpaceX exposure,” said Angelo Bochanis at Renaissance Capital to Reuters. Shay Boloor from Futurum Equities backed the lofty valuation, pointing to Starlink as the key driver. Reuters
That’s shaped sentiment across the sector. Reuters, pulling from Seraphim Space data, said global space company investment jumped to a record $7.95 billion in the first quarter—almost twice what came in last quarter. Lucas Bishop at Seraphim described the mood as “risk-on,” with capital flowing into what investors see as category leaders. Reuters
Rocket Lab isn’t SpaceX. Smaller, unprofitable, and leaning on performance from Electron, Space Systems, and its upcoming Neutron rocket, the firm’s juggling a lot. Public names like AST SpaceMobile and Planet Labs tend to trade off the SpaceX narrative too, but their focus is elsewhere—satellite broadband for AST, Earth imaging for Planet.
Investors could be pricing in a lot of optimism already. A Seeking Alpha analysis out Monday flagged Rocket Lab’s valuation as still steep—enterprise value-to-sales ratios are well above the sector average. That report also pointed out that sentiment hinges on Neutron’s schedule and whether the late-2026 launch stays on track.
Brokers are mostly leaning positive, but it’s not a unanimous call. According to MarketBeat on Sunday, 17 analysts tracking Rocket Lab still land on a “Moderate Buy” consensus, shooting for an average 12-month price target near $83.31. However, the firm also pointed to a spike in short interest—essentially, more traders betting against the stock—which they flagged as a risk for higher volatility. MarketBeat
Right now, it’s straightforward: Rocket Lab holds the contracts and has recent launches in the bag, turning heads across the sector. The company’s stock? That still faces a tougher valuation check—growth alone won’t cut it.
